Title:
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)
Authors:
Bamias, A
Dafni, U
Karadimou, A
Timotheadou, E
Aravantinos, G
Psyrri, A
Xanthakis, I
Tsiatas, M
Koutoulidis, V
Constantinidis, C
others
